FDA Alert: Antipsychotic drugs: Class Labeling Change - Treatment During Pregnancy and Potential Risk to Newborns
Links shared publicly online about this topic.
- 487total visits
FDA Alert: Antipsychotic drugs: Class Labeling Change - Treatment During Pregnancy and Potential Risk to Newborns
FDA Alert: Antipsychotic drugs: Class Labeling Change - Treatment During Pregnancy and Potential Risk to Newborns
View full resource at drugs.com
Tags: Antipsychotic Medication, Drug, Children's Health, Pregnancy, FDA
Most Recently Shared on February 22, 2011 at 9:50 pm By:
FDA Alert - Labeling Change: Antipsychotic Drugs - Treatment During Pregnancy and Potential Risk to Newborns - http://bit.ly/hrVsMi
Advertisement
